Jump to section
To break down barriers to substance use care that works.
Pelago, formerly known as Quit Genius, was founded by a team of medical professionals who observed the lack of clear guidance from doctors on how to effectively quit smoking.
The core of Pelago's product revolves around cognitive behavioral therapy (CBT), a proven method for behavioral change. By focusing on replacing negative thoughts and feelings that trigger smoking with healthier, more positive alternatives, Pelago aids users on their journey to quit smoking. Recognizing the staggering $146 billion annual cost of smoking to employers, Pelago collaborates with businesses to reach and support users in their quest to quit.
However, Pelago's mission goes beyond personal wellness, aspiring to address a broader issue. The company believes that by targeting behavioral patterns, it has the potential to prevent a significant portion of the 40% of premature deaths currently attributed to such patterns, a figure that exceeds the impact of the $3 trillion spent globally on healthcare, which currently prevents only 10% of premature deaths. Notably, Pelago's effectiveness is underscored by a study published in JMIR mHealth, which found that it outperformed the NHS Smoke-free app - an impressive feat for a relatively new startup.
Steph
Company Specialist at Welcome to the Jungle
Mar 2024
$58m
SERIES C
Aug 2022
$15.3m
LATE VC
This company has top investors
Yusuf Sherwani
(Co-Founder & CEO)Previously founder of Unique Melody, an in-ear headphone brand. Also a Clinical Entrepreneur Fellow at the NHS.
Maroof Ahmed
(Co-Founder & COO)Previously the founder and CEO of Interview Doctors (a tuition company for aspiring doctors).
Sarim Siddiqui
(Co-Founder)Previously Doctor at Imperial College. Also a Clinical Entrepreneur Fellow at the NHS.